Pharmadrug Inc.
PHRX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 40.68% | 66.35% | -203.63% | -4,857.62% | 65.76% |
| Total Depreciation and Amortization | -- | -- | -- | 371.83% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -45.68% |
| Total Other Non-Cash Items | 31.37% | -10.84% | 398.26% | 355.26% | 103.69% |
| Change in Net Operating Assets | -19.17% | -251.59% | -206.26% | -- | -- |
| Cash from Operations | 94.09% | -54.55% | -491.35% | -100.52% | 95.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.29% | -- |
| Cash from Investing | -- | -- | -- | 678.29% | 122.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 380.51% | 428.97% | -48.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -76.92% | 100.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -106.25% | -12,566.67% | -161,400.00% | 2,094.78% | 1,596.97% |
